Dr. Rohan Singh Paul, MD

Dr. Paul practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Paul's NPI, 1255606422, was assigned on March 20, 2012. Dr. Paul holds Missouri license 2022037295.

Dr. Paul's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Paul also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Paul's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Paul is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Paul to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paul practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Paul's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Paul is licensed in Missouri.

CMS data shows 1,018 Medicare services from Dr. Paul across 8 procedure codes in 2024, for 364 Medicare patients. Medicare paid $75,970 for them.

CMS counts 364 Medicare patients who saw Dr. Paul in 2024. The largest group is under 65, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 5.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paul's median patient age at 63, with 37% women.

In 2024, Dr. Paul wrote 3,223 Medicare Part D claims for 450 patients. 96% of them were for generic drugs. CMS names the drug for 3,001 of them, across 43 drugs with 11 or more claims each, at $116,609 in total drug cost. In 2023, CMS named 969 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Paul for performance year 2024, reported as part of a group. Dr. Paul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paul as offering telehealth.

Dmand AI links 5 papers to Dr. Paul, published from 2017 to 2021. 2021 was the busiest year, with 3. Dr. Paul has published most often in Transplant Direct. Dr. Paul's most frequent co-authors are Dominic Raj, MD, Elizabeth Dominic Barrows and Jonathan Scott Bromberg, MD.

CMS Open Payments shows 4 general payments to Dr. Paul from 1 drug or device company from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $87.